External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer

Lung cancer is the second most fatal disease worldwide. In the last few years, radiomics is being explored to develop prediction models for various clinical endpoints in lung cancer. However, the robustness of radiomic features is under question and has been identified as one of the roadblocks in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Ashish Kumar, Sherkhane, Umeshkumar B., Mthun, Sneha, Jaiswar, Vinay, Purandare, Nilendu, Prabhash, Kumar, Wee, Leonard, Rangarajan, Venkatesh, Dekker, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584779/
https://www.ncbi.nlm.nih.gov/pubmed/37735307
http://dx.doi.org/10.1007/s10278-023-00835-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584779/
https://www.ncbi.nlm.nih.gov/pubmed/37735307
http://dx.doi.org/10.1007/s10278-023-00835-8

Ejemplares similares